middle.news
Vitrafy Advances No-Wash Platelet Tech and Eyes FDA Milestone Amid Supply Delays
8:54am on Tuesday 28th of April, 2026 AEST
•
Healthcare
Read Story
Vitrafy Advances No-Wash Platelet Tech and Eyes FDA Milestone Amid Supply Delays
8:54am on Tuesday 28th of April, 2026 AEST
Key Points
Phase II platelet study confirms superior no-wash cryopreservation
Commercial traction grows in U.S. military and civilian blood markets
IMV partnership advances with animal health testing underway
Guardion device manufacturing delayed by supply constraints
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Vitrafy Life Sciences (ASX:VFY)
OPEN ARTICLE